Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
It is crucial to protect the product from direct light and moisture to prevent degradation
SURMOUNT-2 (Obesity with T2D) Perhaps the most anticipated trial in the program, SURPASS-2 was a 40-week, head-to-head study comparing Tirzepatide (5, 10, and 15 mg) to the highest approved dose of the potent selective GLP-1 RA, semaglutide (1 mg), in 1,878 patients with T2D on a background of metformin
Incorrect methods can lead to a less effective or even unsafe product
They work gradually, and patience is essential
US$ 21.01
US$ 24.45
US$ 29.34
US$ 26.66
US$ 28.68
US$ 26.00
US$ 25.54
US$ 24.05
US$ 26.06
US$ 29.55
